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Abstract 
Retroviral infections create a large population of cells, each defined by a unique proviral 
insertion site. Methods based on short-read high throughput sequencing can identify 
thousands of insertion sites, but the proviruses within remain unobserved. We have 
developed Pooled CRISPR Inverse PCR sequencing (PCIP-seq), a method that leverages 
long reads on the Oxford Nanopore MinION platform to sequence the insertion site and its 
associated provirus. We have applied the technique to three exogenous retroviruses, HTLV-
1, HIV-1 and BLV, as well as endogenous retroviruses in both cattle and sheep. The long 
reads of PCIP-seq improved the accuracy of insertion site identification in repetitive regions 
of the genome. The high efficiency of the method facilitated the identification of tens of 
thousands of insertion sites in a single sample. We observed thousands of SNPs and dozens 
of structural variants within proviruses and uncovered evidence of viral hypermutation, 
recombination and recurrent selection.  
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Introduction 
The integration of viral DNA into the host genome is a defining feature of the retroviral life 
cycle, irreversibly linking provirus and cell. This intimate association facilitates viral 
persistence and replication in somatic cells, and with integration into germ cells bequeaths 
the provirus to subsequent generations. Considerable effort has been expended to 
understand patterns of proviral integration, both from a basic virology stand point, and due to 
the use of retroviral vectors in gene therapy1. The application of next generation sequencing 
(NGS) over the last ~10 years has had a dramatic impact on our ability to explore the 
landscape of retroviral integration for both exogenous and endogenous retroviruses. Methods 
based on ligation mediated PCR and Illumina sequencing have facilitated the identification of 
hundreds of thousands of insertion sites in exogenous viruses such as Human T-cell 
leukemia virus-1 (HTLV-1)2 and Human immunodeficiency virus (HIV-1)3. These techniques 
have shown that in HTLV-12, Bovine Leukemia Virus (BLV)4, Avian Leukosis Virus (ALV)5 and 
HIV-16 integration sites are not random, most likely reflecting clonal selection. In HIV-1 it has 
also become apparent that provirus integration can drive clonal expansion3 and contribute to 
the HIV-1 reservoir, placing a major road block in the way of a complete cure. 
Current methods based on short-read sequencing identify the insertion point but the 
provirus its-self is unexplored. Whether variation in the provirus influences the fate of the 
clone remains difficult to investigate. Using long range PCR it has been shown that proviruses 
in HTLV-1 induced Adult T-cell leukemia (ATL) are frequently (~45%) defective7, although the 
abundance of defective proviruses within asymptomatic HTLV-1 carriers has not been 
systematically investigated. Recently, there has been a concerted effort to better understand 
the structure of HIV-1 proviruses in the latent reservoir. Methods such as Full-Length 
Individual Proviral Sequencing (FLIPS) have been developed to identify functional 
proviruses8, however these methods do not provide information on the provirus integration 
site, removing the possibility of tracking clone abundance and persistence over time. 
Retroviruses are primarily associated with the diseases they provoke through the infection 
of somatic cells. Over the course of evolutionary time they have also played a major role in 
shaping the genome. Retroviral invasion of the germ line has occurred multiple times, 
resulting in the remarkable fact that endogenous retrovirus (ERV)-like elements comprise a 
larger proportion of the human genome (8%) than protein coding sequences (~1.5%)9. With 
the availability of multiple vertebrate genome assemblies, much of the focus has been on 
comparison of ERVs between species. However, single genomes represent a fraction of the 
variation within a species, prompting some to take a population approach to investigate ERV–
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host genome variation10. While capable of identifying polymorphic ERVs in the population, 
approaches relying on conventional paired-end libraries and short reads cannot capture the 
sequence of the provirus beyond the first few hundred bases of the proviral long terminal 
repeat (LTR), leaving the variation within uncharted. 
The application of NGS as well as Sanger sequencing before, has had a large impact on 
our understanding of both exogenous and endogenous proviruses. The development of long-
read sequencing, linked-read technologies and associated computational tools11 have the 
potential to explore questions inaccessible to short reads. Groups investigating Long 
interspersed nuclear elements-1 (LINE-1) insertions12 and the koala retrovirus, KoRV13 have 
highlighted this potential and described techniques utilizing the Oxford Nanopore and PacBio 
platforms, to investigate insertion sites and retroelement structure. 
To more fully exploit the potential of long reads we developed Pooled CRISPR Inverse 
PCR sequencing (PCIP-Seq), a method that leverages selective cleavage of circularized 
DNA fragments carrying proviral DNA with a pool of CRISPR guide RNAs, followed by inverse 
long-range PCR and multiplexed sequencing on the Oxford Nanopore MinION platform. 
Using this approach, we can now simultaneously identify the integration site and track clone 
abundance while also sequencing the provirus inserted at that position. We have successfully 
applied the technique to the retroviruses HTLV-1, HIV-1 and BLV as well as endogenous 
retroviruses in cattle and sheep. 
 
Results 
Overview of PCIP-seq (Pooled CRISPR Inverse PCR-sequencing) 
The genome size of the retroviruses targeted ranged from 6.8 to 9.7kb, therefore we chose 
to shear the DNA to ~8kb in length. In most cases this creates two fragments for each 
provirus, one containing the 5’ end with host DNA upstream of the insertion site and the 
second with the 3’ end and downstream host DNA. Depending on the shear site the amount 
of host and proviral DNA in each fragment will vary (Fig. 1a). To facilitate identification of the 
provirus insertion site we carry out intramolecular ligation, followed by digestion of the 
remaining linear DNA. To selectively linearize the circular DNA containing proviral sequences, 
regions adjacent to the 5’ and 3’ LTRs in the provirus are targeted for CRISPR mediated 
cleavage. We sought a balance between ensuring that the majority of the reads contained 
part of the flanking DNA (for clone identification) while also generating sufficient reads 
extending into the midpoint of the provirus. We found that using a pool of CRISPR guides for 
each region increased the efficiency and by multiplexing the guide pools and PCR primers 
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for the 5’ and 3’ ends we could generate coverage for the majority of the provirus in a single 
reaction (Fig. 1b). The multiplexed pool of guides and primers leaves coverage gaps in the 
regions flanked by the primers. To address these coverage gaps we designed a second set 
of guides and primers. Following separate CRISPR cleavage and PCR amplification the 
products of these two sets of guides and primers were combined for sequencing (Fig. 1c). 
This approach ensured that the complete provirus was sequenced (Fig. 1d). 
 
Identifying genomic insertions and internal variants in human retroviruses 
Adult T-cell leukemia (ATL) is an aggressive cancer induced by HTLV-1. It is generally 
characterized by the presence of a single dominant malignant clone, identifiable by a unique 
proviral integration site. We and others have developed methods based on ligation mediated 
PCR and Illumina sequencing to simultaneously identify integration sites and determine the 
abundance of the corresponding clones. We initially applied PCIP-seq to two HTLV-1 induced 
cases of ATL, both previously analyzed with our Illumina based method (ATL24 & ATL10014). 
In ATL100 both methods identify a single dominant clone, with >95% of the reads mapping 
to a single insertion site on chr18 (Fig. 2a, 2b & Table1). Using the integration site information, 
we extracted the PCIP-seq hybrid reads spanning the provirus/host insertion site, uncovering 
a ~3,600bp deletion within the provirus (Fig. 2c). 
 In the case of ATL2, PCIP-seq showed three major proviruses located on chr5, chr16 
and chr1, each responsible for 33.9%, 33.2% and 31.2% of the HTLV-1/host hybrid reads 
respectively. We had previously established that these three proviruses are in a single clone 
via examination of the T-cell receptor gene rearrangement4. However, it is interesting to note 
that this was not initially obvious using our Illumina based method as the proviral insertion 
site on chr1 falls within a repetitive element (LTR) causing many of the reads to map to 
multiple regions in the genome. If multi mapping reads are filtered out, the chr1 insertion site 
accounted for 2.6% of the remaining reads, while retaining multi mapping produces values 
closer to reality (25.9%). In contrast the long reads from PCIP-seq allow unambiguous 
mapping and closely matched the expected ~33% for each insertion site (Fig. 2d), 
highlighting the advantage long reads have in repetitive regions. Looking at the three 
proviruses, proviral reads revealed all to be full length. Three de novo mutations were 
observed in one provirus and a single de novo mutation was identified in the second (Fig. 
2e). 
 As a proof of concept, we also applied the technique to U115, a HIV-1 cell line containing 
replication competent proviruses, that shows evidence of ongoing viral replication16. As 
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expected, PCIP-seq found the major insertion sites on chr2 and chrX (accounting for 56% & 
42% of the hybrid reads respectively). It has been reported that both proviruses have 
defective Tat function17 and we observed the mutation disrupting the ATG initiation codon in 
the chr2 provirus and the H-to-L mutation at amino acid 13 in the chrX provirus 
(Supplementary Fig. 1a). In addition to the two major proviruses we identified an additional 
~1,200 low abundance insertion sites (Table 1). We manually inspected the proviruses from 
the ~50 most abundant insertion sites. Of these, an insertion site on chr19 (0.3%) was 
reported by Symons et al 201716. This provirus as well as a second on chr7 were found to be 
the products of recombination between the major chrX and chr2 proviruses (Supplementary 
Fig. 1b). Additionally, two proviruses showed high levels of G-to-A mutations, indicating 
hypermutation by the APOBEC3G protein, a component of the innate anti-viral immune 
response18 (Fig. 3 & Supplementary Fig. 2). Taken together these results suggest PCIP-seq 
as a useful tool for analyzing the HIV-1 reservoir. 
 
Insertion sites identified in samples with multiple clones of low abundance  
The samples utilized above represent a best-case scenario, with ~100% of cells infected and 
a small number of major clones. However, samples like this are the exception rather than the 
rule in most infected individuals. To be broadly applicable, PCIP-seq should be able to identify 
thousands of insertion sites in samples with large numbers of low abundance clones, where 
each clone is defined via a unique proviral insertion site. It should also identify insertion sites 
when only a small fraction of the cells carries the provirus. To test these potential limitations, 
we applied PCIP-seq to four samples from BLV infected sheep (experimental infection19) and 
three cattle (natural infection) to explore its performance on polyclonal and low proviral load 
(PVL) samples and compared PCIP-seq to our previously published Illumina method4. PCIP-
seq revealed all samples to be highly polyclonal (Supplementary Fig. 3 and Table 1) with the 
number of insertion sites identified varying from 233 in the bovine sample 560 (1μg template, 
PVL 0.644%) to 21,579 in bovine sample 1053 (6μg template, PVL 23.5%). In general, PCIP-
seq identified more insertion sites, using less input DNA than our Illumina based method 
(Supplementary Table 1). Comparison of the results showed a significant overlap between 
the two methods. When we consider insertion sites supported by more than three reads in 
both methods (larger clones, more likely to be present in both samples), in the majority of 
cases >70% of the insertion sites identified in the Illumina data were also observed via PCIP-
seq (Supplementary Table 1). These results show the utility of PCIP-seq for insertion site 
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identification, especially considering the advantages long reads have in repetitive regions of 
the genome. 
 
Identifying SNPs in BLV proviruses 
Proviruses with more than 10 supporting reads were examined for SNPs with LoFreq20. For 
the four sheep samples, the variants were called relative to the pBLV344 provirus (used to 
infect the animals). For the bovine samples 1439 and 1053 custom consensus BLV 
sequences were generated for each and the variants were called in relation to the appropriate 
reference (SNPs were not called in 560). Across all the samples 20,283 proviruses were 
examined, 3,085 SNPs were called and 2,565 (13%) of the proviruses carried one or more 
SNPs (Supplementary Table 2). We validated 10 BLV SNPs in the ovine samples and 15 in 
the bovine via clone specific long-range PCR and Illumina sequencing (Supplementary Fig. 
4). For Ovine 221, which was sequenced twice with an ~2-year interval, we identified six 
instances where the same SNP and provirus were observed at both time points. We noted a 
small number of positions in the BLV provirus prone to erroneous SNP calls. By comparing 
allele frequencies from bulk Illumina and Nanopore data these problematic positions could 
be identified (Supplementary Fig. 5a). 
 Within each individual, between ~30% and ~49% of the SNPs were found in multiple 
proviruses. Generally, SNPs found at the same position in multiple proviruses were 
concentrated in a single individual, indicating their presence in a founder provirus or via a 
mutation in the very early rounds of viral replication (Supplementary Fig. 5b). Alternatively, a 
variant may also rise in frequency due to increased fitness of clones carrying a mutation in 
that position. In this instance, we would expect to see the same position mutated in multiple 
individuals. One potential example is found in the first base of codon 303 (position 8155) of 
the viral protein Tax, a potent viral transactivator, stimulator of cellular proliferation and highly 
immunogenic21. A variant was observed at this position in multiple proviruses (14, 18 and 2 
respectively) in the ovine samples 233, 221 (022016) & 220, in one provirus from bovine 
1053 and in two for bovine 1439 (Fig. 4). The majority of the variants observed were G-to-A 
transitions (results in E-to-K amino acid change), however we also observed G-to-T (E-to-
STOP) and G-to-C (E-to-Q) transversions. It has been previously shown that the G-to-A 
mutation abolishes the Tax proteins transactivator activity21,22. The repeated selection of 
variants in this specific position suggests that they reduce viral protein recognition by the 
immune system, while preserving the Tax proteins other proliferative properties. 
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 Patterns of provirus-wide hypermutation (G-to-A) seen within HIV-1 were not observed 
in BLV. However, three proviruses (two from sheep 233 and one in bovine 1053) showed 
seven or more A-to-G transitions, confined to a ~70bp window in the first half of the U3 portion 
of the 3’LTR. The pattern of mutation, as well as their location in the provirus suggests the 
action of RNA adenosine deaminases 1 (ADAR1)23,24. 
 
PCIP-seq identifies BLV structural variants in multiple clones  
The same set of proviruses (with more than 10 supporting reads) used for calling SNPs were 
also examined for structural variants (SVs) using a custom script and visualization of 
proviruses (see methods). Between the sheep and bovine samples, we identified 66 deletions 
and 3 tandem duplications, with sizes ranging from 15bp to 4,152bp, with a median of 113bp 
(Supplementary Table 3). We validated 14 of these via clone specific PCR (Supplementary 
Fig. 7). As seen in Fig. 5 SVs were found throughout the majority of the provirus, 
encompassing the highly expressed microRNAs25 as well as the second exon of the 
constitutively expressed antisense transcript AS126. Only two small regions at the 3’ end 
lacked any SVs. More proviruses will need to be examined to see if this pattern holds, but 
these results again suggest the importance of the 3’LTR and its previously reported 
interactions with adjacent host genes4. 
 
Identifying full-length and polymorphic endogenous retroviruses in cattle and sheep  
ERVs in the genome are generally present as full length, complete provirus, or more 
commonly as solo-LTRs, the products of non-allelic recombination27. At the current time 
conventional short read sequencing, using targeted or whole genome approaches, cannot 
distinguish between the two classes. Examining full length ERVs would provide a more 
complete picture of ERV variation, while also revealing which elements can produce de novo 
ERV insertions. As PCIP-seq targets inside the provirus we can preferentially amplify full 
length ERVs, opening this type of ERV to study in larger numbers of individuals. As a proof 
of concept we targeted the class II bovine endogenous retrovirus BERVK2, known to be 
transcribed in the bovine placenta28. We applied the technique to three cattle, one (10201e6) 
was a Holstein suffering from cholesterol deficiency, an autosomal recessive genetic defect 
recently ascribed to the insertion of a 1.3kb LTR in the APOB gene29. PCIP-seq clearly 
identified the APOB ERV insertion in 10201e6 and in contrast to previous reports29 shows it 
to be a full-length element (Supplementary Fig. 8). We identified a total of 67 ERVs, with 8 
present in all three samples (Supplementary Table 4). We validated three ERVs via long 
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range PCR and Illumina sequencing (Supplementary Fig. 9). We did not find any ERVs with 
an identical sequence to the APOB ERV, although the ERV BTA3_115.3 has an identical LTR 
sequence, highlighting that the sequence of the LTR cannot be used to infer the complete 
sequence of the ERV (Supplementary Fig. 10). 
 We also adapted PCIP-seq to amplify the Ovine endogenous retrovirus Jaagsiekte 
sheep retrovirus (enJSRV), a model for retrovirus-host co-evolution30. Using two sheep (220 
& 221) as template we identified a total of 48 enJSRV proviruses, (33 in 220 and 38 in 221, 
with 22 common to both) and of these ~54% were full length (Supplementary Table 5). We 




In the present report we describe how PCIP-seq can be utilized to identify insertion sites while 
also sequencing the associated provirus and confirm this methodology is effective with a 
number of different retroviruses. For insertion site identification, the method was capable of 
identifying more than ten thousand BLV insertion sites in a single sample, using ~4μg of 
template DNA. Even in samples with a PVL of 0.66%, it was possible to identify hundreds of 
insertion sites with only 1μg of DNA as template. The improved performance of PCIP-seq in 
repetitive regions further highlights its utility, strictly from the standpoint of insertion site 
identification. In addition to its application in research, high throughput sequencing of 
retrovirus insertion sites has shown promise as a clinical tool to monitor ATL progression14. 
Illumina based techniques require access to a number of capital-intensive instruments. In 
contrast PCIP-seq libraries can be generated, sequenced and analyzed with the basics found 
in most molecular biology labs, additionally, preliminary results are available just minutes 
after sequencing begins31. As a consequence, the method may have use in a clinical context 
to track clonal evolutions in HTLV-1 infected individuals, especially as the majority of HTLV-1 
infected individuals live in regions of the world with poor biomedical infrastructure32.  
The inability to easily link variation in the provirus to a specific insertion site is an especially 
pressing problem for the HIV-1 reservoir. Only a small fraction of proviruses (2.4%) in the 
reservoir are intact, yet these are more than sufficient for the disease to rebound if 
antiretroviral therapy is removed33. As strategies are developed to target these intact 
proviruses it will be essential to distinguish between the intact and defective proviruses33. 
Using PCIP-seq in the HIV-1 cell line U1 we identified thousands of minor insertion sites, 
readily finding examples of recombination and hypermutation. This approach could be 
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applied equally well to monitoring the abundance and persistence of intact HIV-1 proviruses 
in patients.  
When analyzing SNPs from BLV two results in particular stood out. Firstly, the presence 
of the recurrent mutations at the first base of codon 303 in the viral protein Tax, a central 
player in the biology of both HTLV-132 and BLV34. It has previously been reported that this 
mutation causes an E-to-K amino acid substitution which ablates the transactivator activity of 
the Tax protein21. Collectively, these observations suggest this mutation confers an 
advantage to clones carrying it, possibly contributing to immune evasion, while retaining Tax 
protein functions that contribute to clonal expansion. However, there is a cost to the virus as 
this mutation prevents infection of new cells due to the loss of Tax mediated transactivation 
of the proviral 5’LTR making it an evolutionary dead end. The second striking observation is 
ADAR1 mediated hypermutation of a ~70bp window in the 3’LTR. ADAR1 hypermutation has 
been observed in a number of viruses23, including the close BLV relatives HTLV-2 and simian 
T-cell leukemia virus type 3 (STLV-3)35. Given its propensity to mutate double stranded RNA 
it is somewhat surprising that ADAR1 has been co-opted by retroviruses to modulate the 
antiviral innate immune response23. Given the small number of hypermutated proviruses 
observed, it appears that this interplay does not result in large numbers of mutated proviruses 
in vivo, although it will be interesting to see it this holds for different retroviruses and at 
different time points during infection. 
In the current study we focused our analysis on retroviruses and ERVs. However, this 
methodology is potentially applicable to a number of different targets. It is estimated that 10-
15% of all cancers have a viral cause, HTLV-1 only represents a small fraction of this number, 
with human papillomaviruses (HPV) and hepatitis B virus (HBV) playing a much bigger role36. 
These viruses are often found integrated into the genome of the cancers they provoke36. In 
contrast to retroviruses, the viral sequence immediately adjacent to the integration site is not 
consistent, reducing the utility of ligation mediated PCR approaches. As a consequence, 
probe based capture methods are required to obtain a genome-wide picture of integration 
sites in these viruses37,38. Using PCIP-seq guides and primers, multiplexed at different points 
in the viral genome, combined with long-reads, it will be possible to identify the viral insertion 
site while also sequencing the virus. This could open many more viral integration sites and 
viral sequences to interrogation, while also exploring precancerous tissue for rare viral 
integrations. Other potential applications include determining the insertion sites and integrity 
of retroviral vectors39, detecting transgenes in genetically modified organisms or identifying 
on target CRISPR–Cas9 mediated structural rearrangement that could be missed by 
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conventional long range PCR40. We envision that in addition to the potential applications 
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Both the BLV infected sheep4 and HTLV-1 samples4,14 have been previously described. 
Briefly, the sheep were infected with the molecular clone pBLV34419, following the 
experimental procedures approved by the University of Saskatchewan Animal Care 
Committee based on the Canadian Council on Animal Care Guidelines (Protocol 
#19940212). The HTLV-1 samples4,14 were obtained with informed consent following the 
institutional review board-approved protocol at the Necker Hospital, University of Paris, 
France, in accordance with the Declaration of Helsinki. The BLV bovine samples were natural 
infections, obtained from commercially kept adult dairy cows in Alberta, Canada. Sampling 
was approved by VSACC (Veterinary Sciences Animal care Committee) of the University of 
Calgary: protocol number: AC15-0159. The bovine 571 used for ERV identification was 
collected as part of this cohort. The two sheep samples used for Jaagsiekte sheep retrovirus 
(enJSRV) identification were the BLV infected ovine samples (220 & 221 (032014)), with a 
PVL of 3.8 and 16% respectively. PBMCs were isolated using standard Ficoll-Hypaque 
separation. The DNA for the bovine Mannequin was extracted from sperm, while the DNA for 
bovine 10201e6 was extracted from whole blood using standard procedures. The HIV-1 U1 
cell line DNA was provided by Dr. Carine Van Lint, IBMM, Gosselies, Belgium. No statistical 
test was used to determine adequate sample size and the study did not use blinding. 
 
PCIP-seq 
DNA isolation was carried out using the Qiagen AllPrep DNA/RNA/miRNA kit. High molecular 
weight DNA was sheared to ~8kb using Covaris g-tubesTM (Woburn, MA) or a Megaruptor 
(Diagenode), followed by end-repair using the NEBNext EndRepair Module (New England 
Biolabs). Intramolecular circularization was achieved by overnight incubation at 16oC with T4 
DNA Ligase. Remaining linear DNA was removed with Plasmid-Safe-ATP-Dependent DNAse 
(Epicentre, Madison WI). Guide RNAs were designed using chopchop 
(http://chopchop.cbu.uib.no/index.php). The EnGen™ sgRNA Template Oligo Designer 
(http://nebiocalculator.neb.com/#!/sgrna) provided the final oligo sequence. Oligos were 
synthesized by Integrated DNA Technologies (IDT). Oligos were pooled and guide RNAs 
synthesized with the EnGen sgRNA Synthesis kit, S. pyogenes (New England Biolabs). 
Selective linearization reactions were performed with the Cas-9 nuclease, S. pyogenes (New 
England Biolabs). PCR primers flanking the cut sites were designed using primer3 
(http://bioinfo.ut.ee/primer3/). Primers were tailed to facilitate the addition of Oxford Nanopore 
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indexes in a subsequent PCR reaction. The linearized fragments were PCR amplified with 
LongAmp Taq DNA Polymerase (New England Biolabs) and a second PCR added the 
appropriate Oxford Nanopore index. PCR products were visualized on a 1% agarose gel and 
quantified on a Nanodrop spectrophotometer. Indexed PCR products were multiplexed and 
Oxford Nanopore libraries prepared with either the Ligation Sequencing Kit 1D (SQK-
LSK108) or 1D^2 Sequencing Kit (SQK-LSK308). The resulting libraries were sequenced on 
Oxford Nanopore MinION R9.4 or R9.5 flow cells respectively and basecalled using albacore 
2.3.1. Only the 1D reads from both flow cell versions were used.  
 
Identification of proviral integrations sites in PCIP-seq 
Reads were mapped with Minimap241 to the host genome with the proviral genome as a 
separate chromosome. In-house R-scripts were used to identify integration sites (IS). Briefly, 
chimeric reads that partially mapped to at least one extremity of the proviral genome were 
used to extract virus-host junctions and shear sites. Junctions within a 200bp window were 
clustered together to form an “IS cluster”, compensating for sequencing/mapping errors. The 
IS retained corresponded to the position supported by the highest number of virus-host 
junctions in each IS cluster. Clone abundance was estimated based on the number of reads 
supporting each IS cluster, reads with the same shear site were considered PCR duplicates. 
A detailed outline of the workflow is available on Github: https://github.com/GIGA-
AnimalGenomics-BLV/PCIP-seq. 
 
Identification of proviral integration sites (Illumina) and measure of proviral load (PVL) 
Integration sites and PVL were determined as previously described in Rosewick et al 20174 
and Artesi et al 201714. 
 
Variant Calling 
After PCR duplicate removal, IS supported by more than 10 reads were retained for further 
processing. SNPs were identified using LoFreq20 with default parameters, only SNP with an 
allele frequency of >0.6 in the provirus associated with the insertion site were considered. 
Deletions were called with a in house R-scripts. Briefly, samtools pileup42 was used to 
calculate/compute coverage and deletions at base resolution. We used the changepoint 
detection algorithm PELT43 to identify genomic windows showing an abrupt change in 
coverage. Windows that showed at least a 4-fold increase in the frequency of deletions 
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(absence of a nucleotide for that position within a read) were flagged as deletions and visually 
confirmed in IGV44. 
 
HIV-1 proviral sequences 
Sequences of the two major proviruses integrated in chr2 and chrX of the U1 cell line were 
generated by initially mapping the reads from both platforms to the HIV-1 provirus, isolate 
NY5 (GenBank: M38431.1), where the 5’LTR sequence is appended to the end of the 
sequence to produce a full-length HIV-1 proviral genome reference. The sequence was then 
manually curated to produce the sequence for each provirus. To check for recombination, 
reads of selected clones were mapped to the sequence from the chrX provirus and the 
patterns of SNPs examined to determine if the variants matched the chrX or chr2 proviruses. 
Hypermutation of the provirus was initially identified by manually inspecting the reads in IGV, 
the consensus sequence from the regions of the provers with coverage >4 was concatenated, 
aligned using CLUSTAL O (1.2.4) and checked for hypermutation with Hypermut 
(https://www.hiv.lanl.gov/content/sequence/HYPERMUT/hypermut.html). 
 
Endogenous retroviruses  
The sequence of bovine APOB ERV was generated by PCR amplifying the full length ERV 
with LongAmp Taq DNA Polymerase (New England Biolabs) from a Holstein suffering from 
cholesterol deficiency. The resultant PCR product was sequenced on the Illumina platform 
as described below. It was also sequenced with an Oxford Nanopore MinION R7 flow cell as 
previously described26. Full length sequence of the element was generated via manual 
curation. Guide RNAs and primer pairs were designed using this ERV reference. For the 
Ovine ERV we used the previously published enJSRV-7 sequence30 as a reference to design 
PCIP guide RNAs and PCR primers.  
 As the ovine and bovine genome contains sequences matching the ERV, mapping ERV 
PCIP-seq reads back to the reference genome creates a large pileup of reads in these 
regions. To avoid this, prior to mapping to the reference we first used BLAST45 to identify the 
regions in the reference genome containing sequences matching the ERV, we then used 
BEDtools46 to mask those regions. The appropriate ERV reference was then added as an 
additional chromosome in the reference.  
 
PCR validation and Illumina sequencing  
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Clone specific PCR products were generated by placing primers in the flanking DNA as well 
as inside the provirus. LongAmp Taq DNA Polymerase (New England Biolabs) was used for 
amplification following the manufacturers guidelines. Resultant PCR products were sheared 
to ~400bp using the Bioruptor Pico (Diagenode) and Nextera XT indexes added as previously 
described26. Illumina PCIP-seq libraries were generated in the same manner. Sequencing 
was carried out on either an Illumina MiSeq or NextSeq 500. Clone specific PCR products 
sequenced on Nanopore were indexed by PCR, multiplexed and libraries prepared using the 
Ligation Sequencing Kit 1D (SQK-LSK108) and sequenced on a MinION R9.4 flow cell.  
 
BLV references  
The sequence of the pBLV344 provirus was generated via a combination of Sanger and 
Illumina based sequencing with manual curation of the sequence to produce a full length 
proviral sequence. The consensus BLV sequences for the bovine samples 1439 & 1053 were 
generated by first mapping the PCIP-seq Nanopore reads to the pBLV344 provirus. We then 
used Nanopolish47 to create an improved consensus. PCIP-seq libraries sequenced on the 
Illumina and Nanopore platform were mapped to this improved consensus visualized in IGV 
and manually corrected. 
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Figure 1. Overview of the PCIP-seq method (a) Simplified outline of method (b) A pool of 
CRISPR guide-RNAs targets each region, the region is flanked by PCR primers. Guides and 
primers adjacent to 5' & 3' LTRs are multiplexed. (c) As the region between the PCR primers 
is not sequenced we created two sets of guides and primers. Following circularization, the 
sample is split, with CRISPR mediated cleavage and PCR occurring separately for each set. 
After PCR the products of the two sets of guides and primers are combined for sequencing. 
(d) Screen shot from the Integrative Genomics Viewer (IGV) showing a small fraction of the 
resultant reads (grey bars) mapped to the provirus, coverage is shown on top, coverage 
drops close to the 5’ and 3’ ends are regions flanked by primers. 
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Figure 2. PCIP-seq applied to ATL (a) In ATL100 both Illumina and Nanopore based methods 
show a single predominant insertion site (b) Screen shot from IGV shows a ~16kb window 
with the provirus insertion site in the tumor clone identified via PCIP-seq and ligation 
mediated PCR with Illumina sequencing (c) PCIP-seq reads in IGV show a ~3,600bp deletion 
in the provirus, confirmed via long range PCR and Illumina sequencing. (d) The ATL2 tumor 
clone contains three proviruses (named according to chromosome inserted into), the provirus 
on chr1 inserted into a repetitive element (LTR) and short reads generated from host DNA 
flanking the insertion site map to multiple positions in the genome. Filtering out multi-mapping 
reads causes an underestimation of the abundance of this insertion site (2.6 %), this can be 
partially corrected by retaining multi-mapping reads at this position (25.9 %). The long PCIP-
seq reads can span repetitive elements and produce even coverage for each provirus without 
correction. (e) Screen shot from IGV shows representative reads coming from the three 
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Figure 3. APOBEC3G hypermutation in the HIV-1 cell line U1 (a) Screen shot from IGV 
shows reads from the proviruses chr17:44.4 and chr7:91.6 aligned to the sequence of the 
major U1 chr2 provirus. The vast majority of the de novo mutations observed in both 
proviruses are G-to-A mutations, the extremely high frequency indicates the action of 
APOBEC3G. (b) The portion of the reads mapping to the host genome shows no evidence 
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Figure 4. Screen shot from IGV shows representative reads from a subset of the clones from 
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Figure 5. Structural variants observed in the BLV provirus. BLV sense and antisense 
transcripts are shown on top. Deletions (blue bars) and duplications (red bars) observed in 
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Table 1 Number of insertion sites (IS) identified via PCIP-seq. Chimeric reads = reads 
containing host and viral DNA. Largest clone % = insertion site with highest number of reads 




Virus Host PVL 
Template 
μg 









ATL2 HTLV-1 HSA nd 4 430,060 63 237 34 
ATL100 HTLV-1 HSA 106 4 35,833 34 235 98 
HIV_U1 HIV-1 HSA nd 2 506,639 50 1,172 54 
233 BLV OAR  78.3 7 1,057,945 46 8,182 8.4 
221 
(022016) 
BLV OAR  63.0 4 391,139 59 11,379 0.7 
221 
(032014) 
BLV OAR  16.0 4 116,726 55 8,335 0.3 
220 BLV OAR  3.8 2 99,054 58 1,921 6.4 
1439 BLV BosT 45.0 3 454,406 66 7,499 1.2 
560 BLV BosT 0.64 1 92,702 41 233 5.3 
1053 BLV BosT 23.5 6 627,074 62 21,579 0.4 
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